No article text was recorded for this version.
positron emission tomography
Version 1 of 151 papers60 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Quantification of [<sup>11</sup>C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations
- Blog: In vivo imaging of mGlu5 receptor expression in humans with Fragile X Syndrome towards development of a potential biomarker
- Blog: Development of Xanamem, an isoform 1 specific inhibitor of 11‐βHSD, as a procognitive and disease modifying treatment for mild/moderate Alzheimer’s disease. A pharmacodynamic and biomarker driven approach
- Blog: Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging
- Blog: 18F–THK–5351, Fluorodeoxyglucose, and Florbetaben PET Images in Atypical Alzheimer’s Disease: A Pictorial Insight into Disease Pathophysiology
- Blog: Longitudinal alterations in gamma-aminobutyric acid (GABAA) receptor availability over ∼ 1 year following traumatic brain injury
- Blog: In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [11C]Celecoxib, a COX-2 PET Ligand, in Nonhuman Primates
- Blog: A Key Mediator and Imaging Target in Alzheimer’s Disease: Unlocking the Role of Reactive Astrogliosis Through MAOB
- Blog: Gamma oscillations in V1 are correlated with GABAA receptor density: A multi-modal MEG and Flumazenil-PET study
- Blog: L-DOPA regulates neuroinflammation and Aβ pathology through NEP and ADAM17 in a mouse model of AD
- Blog: APOE4 moderates the association between cerebral small vessel disease and cortical tau accumulation in midlife
- Blog: Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer’s disease
- Blog: KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
- Blog: [18F]florbetapir PET for early detection of amyloidosis in patients with hereditary transthyretin amyloidosis polyneuropathy
- Blog: Influence of Serotonin Transporter Gene Polymorphism (5-HTTLPR Polymorphism) on the Relation between Brain 5-HT Transporter Binding and Heart Rate Corrected Cardiac Repolarization Interval
- Blog: Dopamine‐transporter levels drive striatal responses to apomorphine in <scp>P</scp>arkinson's disease
- Blog: mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia
- Blog: PET-measured human dopamine synthesis capacity and receptor availability predict trading rewards and time-costs during foraging
- Blog: Effect of tau on global graph measures from high‐density EEG in preclinical and prodromal stage of Alzheimer disease
- Blog: Donepezil ameliorates Aβ pathology but not tau pathology in 5xFAD mice
- Blog: Quantification of Amyloid and Tau associations in the Piriform Cortex in Alzheimer's and Parkinson's Disease using PET‐MR
- Blog: GABAA receptor availability relates to emotion-induced BOLD responses in the medial prefrontal cortex: simultaneous fMRI/PET with [11C]flumazenil
- Blog: Disruption of ClC-3-mediated 2Cl−/H+ exchange leads to behavioural deficits and thalamic atrophy
- Blog: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
- Blog: Diagnostic accuracy of dual-phase 18F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism
- Blog: Subtype‐specific patterns of tau pathology in Alzheimer’s and related disorders
- Blog: GABAergic inhibition shapes behavior and neural dynamics in human visual working memory
- Blog: The Influence of Cerebrospinal Fluid Abnormalities and APOE 4 on PHF-Tau Protein: Evidence From Voxel Analysis and Graph Theory
- Blog: Attenuation of dopamine-modulated prefrontal value signals underlies probabilistic reward learning deficits in old age
- Blog: Frontostriatal and Dopamine Markers of Individual Differences in Reinforcement Learning: A Multi-modal Investigation
- Blog: Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease
- Blog: Salivary DJ-1 could be an indicator of Parkinson's disease progression
- Blog: Lipopolysaccharide endotoxemia induces amyloid-β and p-tau formation in the rat brain.
- Blog: Nonfluent/Agrammatic PPA with In-Vivo Cortical Amyloidosis and Pick’s Disease Pathology
- Blog: Longitudinal associations between β-amyloid and cortical thickness in mild cognitive impairment
- Blog: Elevated serum cortisol associated with early‐detected increase of brain amyloid deposition in Alzheimer's disease imaging biomarkers among menopausal women: The Framingham Heart Study
- Blog: Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease
- Blog: Cellular and molecular associations with intrinsic brain organization
- Blog: Combining Diagnostic Imaging and Pathology for Improving Diagnosis and Prognosis of Cancer
- Blog: Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer’s disease
- Blog: Pharmacokinetic Evaluation of the Tau PET Radiotracer <sup>18</sup>F-T807 (<sup>18</sup>F-AV-1451) in Human Subjects
- Blog: Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
- Blog: Impaired theta phase coupling underlies frontotemporal dysconnectivity in schizophrenia
- Blog: Metabolic glutamate receptor 5 (mGluR5) is associated with tau pathology in mild Alzheimer's disease
- Blog: Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution
- Blog: Tau Positron Emission Tomography and Neurocognitive Function Among Former Professional American-Style Football Players
- Blog: Myocardial 11C-diacylglycerol accumulation and left ventricular remodeling in patients after myocardial infarction.
- Blog: Research progress of multimodal biomarkers in the early diagnosis of mild cognitive impairment in Parkinson’s disease
- Blog: Histamine H3 Receptor as a target for alcohol use disorder: challenging the predictability of animal models for clinical translation in drug development
- Blog: <scp>mGluR<sub>5</sub></scp> and <scp>GABA<sub>A</sub></scp> receptor‐specific parametric <scp>PET</scp> atlas construction—<scp>PET</scp>/<scp>MR</scp> data processing pipeline, validation, and application
- Blog: Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer’s Continuum
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_positron_emission_tomography_2b0e3af3,
title = {positron emission tomography},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/positron-emission-tomography/rdr_2b0e3af303044828881404f21b7fb2a3},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_positron_emission_tomography_2b0e3af3_v1,
title = {positron emission tomography},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/positron-emission-tomography/rdr_2b0e3af303044828881404f21b7fb2a3/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}